SG

Seattle Genetics

- NASDAQ:SGEN
Last Updated 2024-04-23
  • Seattle Genetics develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

  • Locations

    • Bothell WA

  • Industries

    Software, Mobile Apps, Real Estate, Cyber Security, Drones

  • Security

    Type: ORD
    CUSIP: 81181C104
    ISIN: US81181C1045
Filter date
All
Bookmark Created by Last updated
Test Long URL sangwon.seo.old 2019-09-24
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo